---
layout: entry
title: "Current status of treatment for 2019 novel coronavirus pneumonia"
link: "https://doi.org/10.3760/cma.j.issn.0254-5101.2020.01.002"
author:
- Zhu, N.; Zhao, P.; Qi, Z.

summary:
- "2019 novel coronavirus (2019-nCoV) can cause serious respiratory diseases. There is no specific antiviral drug targeting 2019-NCoV. This paper reviewed the current research situation and progress in drug treatment strategies for the newly identified disease. At present, there is no particular antivirals drug targeting the disease, which can cause severe acute respiratory syndrome-corona virus (SARS-CoV), and middle east respiratory syndrome. A new member of the family is a new member. of coronan influenza is emergence of severe nCovirus can cause acute respiratory diseases after the emergence."

original:
- "2019 novel coronavirus (2019-nCoV) is a new member of coronavirus family that can cause serious respiratory diseases after the emergence of severe acute respiratory syndrome-coronavirus (SARS-CoV) and middle east respiratory syndrome-coronavirus (MERS-CoV). At present, there is no specific antiviral drug targeting 2019-nCoV. In facing of the increasingly serious epidemic of 2019-nCoV pneumonia and the urgent needs in drug treatment strategies, this paper reviewed the current research situation and progress in antiviral treatment for the newly identified disease."
---

